Warning: Missing argument 1 for get_page_builder(), called in /home/v8dev/public_html/main/wp-content/themes/Volum8WP/template-current-trials.php on line 66 and defined in /home/v8dev/public_html/main/wp-content/themes/Volum8WP/assets/functions/page-builder/get-page-builder.php on line 3

Notice: Undefined variable: page_id in /home/v8dev/public_html/main/wp-content/themes/Volum8WP/assets/functions/page-builder/get-page-builder.php on line 11

Notice: Undefined variable: page_id in /home/v8dev/public_html/main/wp-content/themes/Volum8WP/assets/functions/page-builder/get-page-builder.php on line 13

Browse the following options to find a clinical trial in your area and find out if you may qualify today!


Notice: Undefined variable: page_id in /home/v8dev/public_html/main/wp-content/themes/Volum8WP/assets/functions/page-builder/get-page-builder.php on line 13

The biggest obstacle in getting a celiac drug to market is recruiting enough patients to participate in clinical trials. We need your help to make better treatments and, one day, a cure for celiac disease a reality.


Notice: Undefined variable: page_id in /home/v8dev/public_html/main/wp-content/themes/Volum8WP/assets/functions/page-builder/get-page-builder.php on line 13

Current Trials

U.S. Multi-Site

PROACTIVE Celiac Study

The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015.

In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.

NO gluten challenge

Requirements:

  • 18-70 years old
  • Biopsy-confirmed celiac disease
  • On a gluten-free diet for at least the last 12 months
  • Still experiencing celiac disease symptoms

Learn more at proactiveceliac.com
Use referral code: REFCDF

U.S. Multi-Site

ACeD Study

Kanyos Bio is looking for volunteers with celiac disease to participate in the ACeD Study (Assessment of KAN-101 in Celiac Disease), a phase 1 clinical trial testing the investigational drug KAN-101.

KAN-101 acts by re-educating T cells, or tolerizing them, so they do not respond to gluten antigens.

Requirements:

  • 18-70 years old
  • Biopsy-confirmed celiac disease
  • On a gluten-free diet for at least the last 12 months

Learn more at Anokion.com/ACeD